Exploring the PD-1/PD-L1 pathway using Data, Tools, and Resources from RCSB.org

Based on case studies presented in doi.org/10.1002...
00:00: Intro to PD-1/PD-L1
01:45: Exploring PDB ID 5jxe - Structure Summary page
04:35 How Pembrolizumab Disrupts PD-1:PD-L1 Binding
05:40 Compare structures
07:28 Other Therapeutic Anti-PD-1 Antibodies
Learn more about Pembrolizumab (pdb101.rcsb.or...) and other cancer therapy approaches on PDB-101 (pdb101.rcsb.org/).

[@benchu3601]

How come Tislelizumab is not approved by the FDA if the molecular structure are the same as the other three Mabs?

[@alptekinakturk4185]

thank you

[@suteners2111]

when we will see pretty cartoon?